8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively.

          Abstract

          Fujinami et al. show that an antimicrobial peptide Nukacin ISK-1 exists in an equilibrium between two states, only one of which can bind to the ISK-1’s target lipid-II, an important bacterial cell wall precursor. This study provides unexpected insights into the action modes of antibiotics.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

          Resistance to antibiotics is increasing in some groups of clinically important pathogens. For instance, high vancomycin resistance has emerged in enterococci. Promising alternative antibiotics are the peptide antibiotics, abundant in host defense systems, which kill their targets by permeabilizing the plasma membrane. These peptides generally do not act via specific receptors and are active in the micromolar range. Here it is shown that vancomycin and the antibacterial peptide nisin Z use the same target: the membrane-anchored cell wall precursor Lipid II. Nisin combines high affinity for Lipid II with its pore-forming ability, thus causing the peptide to be highly active (in the nanomolar range).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Where will new antibiotics come from?

            There is a constant need for new antibacterial drugs owing to the inevitable development of resistance that follows the introduction of antibiotics to the clinic. When a new class of antibiotic is introduced, it is effective at first, but will eventually select for survival of the small fraction of bacterial populations that have an intrinsic or acquired resistance mechanism. Pathogens that are resistant to multiple drugs emerge around the globe, so how robust are antibiotic discovery processes?
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes

              Lanthipeptides are ribosomally synthesized and post-translationally modified peptides (RiPPs) that display a wide variety of biological activities, from antimicrobial to antiallodynic. Lanthipeptides that display antimicrobial activity are called lantibiotics. The post-translational modification reactions of lanthipeptides include dehydration of Ser and Thr residues to dehydroalanine and dehydrobutyrine, a transformation that is carried out in three unique ways in different classes of lanthipeptides. In a cyclization process, Cys residues then attack the dehydrated residues to generate the lanthionine and methyllanthionine thioether cross-linked amino acids from which lanthipeptides derive their name. The resulting polycyclic peptides have constrained conformations that confer their biological activities. After installation of the characteristic thioether cross-links, tailoring enzymes introduce additional post-translational modifications that are unique to each lanthipeptide and that fine-tune their activities and/or stability. This review focuses on studies published over the past decade that have provided much insight into the mechanisms of the enzymes that carry out the post-translational modifications.
                Bookmark

                Author and article information

                Contributors
                +81 926426968 , kohda@bioreg.kyushu-u.ac.jp
                +81 926423019 , sonomoto@agr.kyushu-u.ac.jp
                Journal
                Commun Biol
                Commun Biol
                Communications Biology
                Nature Publishing Group UK (London )
                2399-3642
                25 September 2018
                25 September 2018
                2018
                : 1
                : 150
                Affiliations
                [1 ]ISNI 0000 0001 2242 4849, GRID grid.177174.3, Division of Structural Biology, Medical Institute of Bioregulation, , Kyushu University, ; Fukuoka, 812-8582 Japan
                [2 ]ISNI 0000 0001 2242 4849, GRID grid.177174.3, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Laboratory of Microbial Technology, , Kyushu University, ; Fukuoka, 812-8581 Japan
                [3 ]ISNI 0000 0000 9611 5902, GRID grid.418046.f, Department of Functional Bioscience, Section of Infection Biology, , Fukuoka Dental College, ; Fukuoka, 814-0175 Japan
                [4 ]Present Address: Microbiology and Industrial Irradiation Division, Institute of Food and Radiation Biology, Atomic Energy Research Establishment, Ganakbari, Savar 1207, Dhaka, 1349 Bangladesh
                [5 ]ISNI 0000 0004 0621 7673, GRID grid.411810.d, Present Address: Department of Microbiology, Faculty of Pharmacy, , Misr International University, ; Cairo, 19648 Egypt
                [6 ]ISNI 0000 0001 1498 6059, GRID grid.8198.8, Present Address: Department of Biochemistry and Molecular Biology, , University of Dhaka, ; Dhaka, 1000 Bangladesh
                Author information
                http://orcid.org/0000-0002-6763-2577
                http://orcid.org/0000-0001-8234-3776
                Article
                150
                10.1038/s42003-018-0150-3
                6156582
                30272026
                1e85e6f4-5eba-4108-bd1b-6596a397b3d8
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 2 April 2018
                : 17 August 2018
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001691, Japan Society for the Promotion of Science (JSPS);
                Award ID: JP26119002, JP26292040
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Comments

                Comment on this article